Ozespa

briakinumab · Abbott Laboratories Limited

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ozespa, covering 2011-01-17 to 2011-01-31. Get the full timeline:

Most recent: EMA Application withdrawn: Ozespa (briakinumab) — Abbott Laboratories Ltd.